Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
979
datasets available to search
ShareScore release 0.9.0
Dataset results
979 results for “HR”
Bone Microarchitectural Database Constitution From HR-pQCT Device in Clinical Situation Potentially Associated With Bone Loss
ClinicalTrials.gov study NCT02532439. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients
ClinicalTrials.gov study NCT04300790. IPD Sharing: NO. Countries: 1. Publications: 0.
A Real-World Study in Patients With HR+/HER2- Advanced Breast Cancer
ClinicalTrials.gov study NCT07076680. IPD Sharing: NO. Countries: 1. Publications: 0.
HR Versus RFA for HCC in Patients With PHT
ClinicalTrials.gov study NCT02192671. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer
ClinicalTrials.gov study NCT05911958. IPD Sharing: NO. Countries: 1. Publications: 0.
JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer
ClinicalTrials.gov study NCT07336771. IPD Sharing: NO. Countries: 1. Publications: 0.
Converting HR+ Breast Cancer Into an Individualized Vaccine
ClinicalTrials.gov study NCT03804944. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence
ClinicalTrials.gov study NCT00682552. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical P
ClinicalTrials.gov study NCT06930859. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metast
ClinicalTrials.gov study NCT04916509. IPD Sharing: NO. Countries: 3. Publications: 0.
Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.
ClinicalTrials.gov study NCT06705127. IPD Sharing: NO. Countries: 1. Publications: 0.
HR-EEG Contribution in Prognostic Evaluation of Language Development in Children With ASD
ClinicalTrials.gov study NCT05586672. IPD Sharing: NO. Countries: 1. Publications: 0.
"Observational, Retrospective and Prospective, Non-interventional, Multicentre on the Use of Genomic Testing in the Management of Early Stage HR+/HER2- Breast Cancer"
ClinicalTrials.gov study NCT06871501. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients
ClinicalTrials.gov study NCT01305239. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior
ClinicalTrials.gov study NCT06998108. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)
ClinicalTrials.gov study NCT07383818. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) a
ClinicalTrials.gov study NCT07340619. IPD Sharing: NO. Countries: 0. Publications: 0.
5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss
ClinicalTrials.gov study NCT07044310. IPD Sharing: Not stated. Countries: 1. Publications: 0.
RWE Non-Interventional Prospective Study of Ribociclib Effectiveness and Safety in Patients With HR+/HER2- Early Breast Cancer in Saudi Arabia
ClinicalTrials.gov study NCT06797531. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Sacituzumab Govitecan With Atropine to Improve Tolerability in Advanced TNBC and HR+/HER2- Breast Cancer
ClinicalTrials.gov study NCT07367178. IPD Sharing: YES. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.